Literature DB >> 8126428

Glucose utilization and lactate production by Helicobacter pylori.

G L Mendz1, S L Hazell, B P Burns.   

Abstract

The transport and incorporation of D-glucose into the human pathogen Helicobacter pylori was investigated employing radioactive tracer analysis and 1H and 13C nuclear magnetic resonance spectroscopy. The bacterium was found to utilize D-glucose contrary to the accepted view that it cannot catabolize carbohydrates. Under the experimental conditions employed, the rate of transport of [14C]glucose was 3.24 mmol min-1 (g protein)-1, and the rate of incorporation into the cellular mass was 1.06 mumol h-1 (g protein)-1. The utilization of [13C]glucose showed biphasic characteristics with a slower initial period followed by a phase with a rate of utilization at least an order of magnitude faster. The apparent rates of decline of glucose levels during both phases varied between strains and depended on the growth conditions of the bacteria prior to harvesting. The main product of glucose catabolism was identified as lactate. These findings provide new perspectives into the physiology of H. pylori and have implications for the active search to develop appropriate therapies for the micro-organism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8126428     DOI: 10.1099/00221287-139-12-3023

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  31 in total

1.  Genome-scale metabolic model of Helicobacter pylori 26695.

Authors:  Christophe H Schilling; Markus W Covert; Iman Famili; George M Church; Jeremy S Edwards; Bernhard O Palsson
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

2.  Idebenone acts against growth of Helicobacter pylori by inhibiting its respiration.

Authors:  Sakiko Inatsu; Ayumi Ohsaki; Kumiko Nagata
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Expression, purification, crystallization and preliminary X-ray analysis of an NADP-dependent glyceraldehyde-3-phosphate dehydrogenase from Helicobacter pylori.

Authors:  Paul R Elliott; Daniel Evans; Jacqueline A Greenwood; Peter C E Moody
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-07-26

4.  Carbon Fixation Driven by Molecular Hydrogen Results in Chemolithoautotrophically Enhanced Growth of Helicobacter pylori.

Authors:  Lisa G Kuhns; Stéphane L Benoit; Krishnareddy Bayyareddy; Darryl Johnson; Ron Orlando; Alexandra L Evans; Grover L Waldrop; Robert J Maier
Journal:  J Bacteriol       Date:  2016-04-14       Impact factor: 3.490

5.  Nutritional requirements for growth of Helicobacter pylori.

Authors:  P Nedenskov
Journal:  Appl Environ Microbiol       Date:  1994-09       Impact factor: 4.792

6.  The Entner-Doudoroff pathway has little effect on Helicobacter pylori colonization of mice.

Authors:  Amy E Wanken; Tyrrell Conway; Kathryn A Eaton
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

7.  Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single- and double-deletion mutants.

Authors:  Ines Thiele; Thuy D Vo; Nathan D Price; Bernhard Ø Palsson
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

8.  Expression, purification, crystallization and preliminary X-ray analysis of an NAD-dependent glyceraldehyde-3-phosphate dehydrogenase from Helicobacter pylori.

Authors:  Paul R Elliott; Shabaz Mohammad; Helen J Melrose; Peter C E Moody
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-07-26

9.  Cloning, expression, and enzymatic characterization of isocitrate dehydrogenase from Helicobacter pylori.

Authors:  Dongsheng Huang; Junwei Liu; Guoliang Shen
Journal:  Protein J       Date:  2009-12       Impact factor: 2.371

10.  Isolation of the Helicobacter pylori recA gene and involvement of the recA region in resistance to low pH.

Authors:  S A Thompson; M J Blaser
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.